Strengthen the PFS CMO business through a long-term partnership with global syringe leader BDExpand the global customer ...

Company Announces Second Closing of $67 Million Series A with New Investment by 8VCCAMBRIDGE, Mass.--(BUSINESS ...

Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of moderate-to-severe acne - SAN DIEGO, CA / ACCESS Newswire / September 17, ...

Third Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / September 17, 2025 / Hemogenyx Pharmaceuticals plc is pleased ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

VELA to operate the world’s first sailing cargo trimaran powered by 100 percent wind when at sea1 to sail between Europe and ...

Located near Tampa, 30,000 sq. ft. facility in Manatee County’s City of Palmetto will house state-of-the-art manufacturing ...

EAACI Prize recognizes the clinical impact of PRT120 and findings from the PPOIT-003LT study, which showed significant ...

ClostraBio, Inc., a biotech company pioneering microbiome-based solutions for gastrointestinal health, today announced two ...

Vizient®, the nation's largest provider-driven healthcare performance improvement company, honored top suppliers and ...

The new medical model delivers 50% fewer keyword errors on clinical terms and 17% lower overall word errors than the next ...

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech ...